The Medtronic-backed medical device maker has pulled in $108m in equity financing just under a year after delisting.

Mainstay Medical, an Ireland-based developer of medical devices for the treatment of back pain that counts medical device manufacturer Medtronic as an investor, has raised $108m in an equity financing. The round was co-led by an unnamed global medical device company, Ally Bridge Group, Sofinnova Partners’ Crossover Fund. They invested together with Sofinnova Partners, KCK…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.